# MOTS-c peptide FAQ: Common Questions, Answered From the Research > MOTS-c peptide FAQ: weight, onset, how it feels, combinations, half-life, legal status, and FDA 503A standing — direct answers drawn from the published literature and cited. Direct, cited answers to the questions people actually ask about MOTS-c — what it does, how long it takes, and where the evidence stops. ## Can MOTS-c Cause Weight Gain? No mechanism for weight gain has been described. In mice, MOTS-c prevented diet-induced obesity and the literature describes increased adipose thermogenesis [1][4]. There are no human interventional weight outcomes, in either direction, from controlled trials. ## How Long Does It Take for MOTS-c to Kick In? There is no validated human onset timeline. Rodent metabolic studies dose chronically over weeks — for example, roughly 0.5 mg/kg/day for about 8 weeks in mice [1]. One mouse study reported improved acute exercise performance after a single dose [2], but that is an animal finding, not a human timeline. ## How Does MOTS-c Make You Feel? No human experiential or subjective-effect data have been published in controlled trials. The literature is limited to laboratory metabolic and performance endpoints in animals [1][2] and biomarker associations in people [6][14], so there is no validated description of how the compound "feels" in humans. ## How Long Does MOTS-c Take to Work? Timelines come only from animal studies, where metabolic effects were measured over multi-week dosing schedules [1]. No human dose-response or time-to-effect has been established, so any specific human timeframe would be unsupported by the published record. ## Does MOTS-c Work Immediately? No. The metabolic literature uses repeated dosing over weeks rather than single administrations [1]. Only acute exercise-performance effects have been reported after a single dose, and that finding is in mice, not people [2]. ## Can MOTS-c Be Combined With Other Metabolic Compounds? No controlled study has evaluated MOTS-c combined with any incretin or other metabolic agent. Combination use is unstudied and falls outside any approved protocol, so the literature provides no safety or efficacy basis for it. ## Is There a Studied MOTS-c Metabolic Stack? There is no validated stack. In preclinical contexts MOTS-c is most often discussed alongside the co-encoded mitochondrial peptide humanin [4], but no combination protocol has been clinically tested in humans. ## Is MOTS-c Legal? MOTS-c is a research peptide — not an FDA-approved drug and not a dietary supplement [16]. It is named on the FDA Pharmacy Compounding Advisory Committee agenda for July 23–24, 2026 as a substance "being considered for inclusion on the 503A Bulks List," which is a scheduled discussion, not a decision [18]. In elite sport it is treated as prohibited. ## Can You Get MOTS-c From a Compounding Pharmacy? Compounded access in general requires a licensed-prescriber evaluation, a valid patient-specific prescription, and a 503A pharmacy or 503B outsourcing facility [16]. A compounder may only use an ingredient eligible under the bulks-substance rules; a substance flagged for significant safety risks is not eligible for routine 503A compounding while that status stands [17]. This is general information, not medical or legal advice. ## What Is the FDA 503A Status of MOTS-c? MOTS-c is a research peptide, not FDA-approved, and is scheduled for evaluation by the FDA Pharmacy Compounding Advisory Committee at its July 23–24, 2026 meeting [18]. The audited regulatory reference assigns it no numbered 503A category. A scheduled PCAC discussion is a step in evaluation, not a final listing decision [16]. --- An exhibition-wall reading of the mitochondrial-derived MOTS-c peptide literature — each study hung as its own plate and cited, the large search demand held apart from the empty human-trial wall, and the FDA research-only standing and July-2026 PCAC agenda noted before anything else; no clinic curates this room and nothing here is dispensed or sold.